Aethlon Medical, a pioneer in developing therapeutic filtration devices to address infectious disease and cancer, has promoted Jim Frakes, currently serving as senior vice president-finance, to chief financial officer (CFO).
Frakes initially joined the company in January 2008 in a part-time role as senior vice president-finance. Prior to joining Aethlon, Frakes served as the CFO of four public companies over a 16-year period.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.